FDA Inspection 1046400 — BioMarin Pharmaceutical Inc.
The FDA completed an inspection of BioMarin Pharmaceutical Inc. on December 7, 2017 in San Rafael, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- December 7, 2017
- Fiscal Year
- 2018
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- San Rafael, CA (United States)
Additional Details
Sponsor, Contract Research Organization